Senior Principal Scientist
Genentech, Inc.
Sebastian Guelman is a Senior Principal Scientist in the BioAnalytical Sciences Department at Genentech. He currently leads the development of bioanalytical strategies to support a number of cancer immunotherapy programs in Genentech’s pipeline, including new modalities such as T cell therapy and the Individualized Neoantigen-specific Immunotherapy. Prior to joining Genentech, Sebastian worked at Iconic Therapeutics, developing pre-clinical pharmacokinetic, immunogenicity and biomarker assays to support an oncology program. Prior to that role, Sebastian worked in the development of immunoassays for clinical diagnostics using different platforms. Sebastian received his PhD degree in Biochemistry and Molecular Biology from the Pennsylvania State University and was a post-doctoral fellow in the Department of Pathology at Genentech.